Extended Data Fig. 2: Waterfall plots of best percentage change from baseline in sum of diameters assessed by investigator in double-blind phase.
a, Sugemalimab plus platinum-based chemotherapy. N = 203 patients. b, Placebo plus platinum-based chemotherapy. N = 64 patients.
